Exagen, Inc. (XGN)

7.18 +0.21 (+3.01%) USD  |  NASDAQ  |  Sep 11, 13:23
More

Exagen Cash from Operations (Annual) : -13.62M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for XGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2012. Start Trial.
Date Value
December 31, 2025 -13.62M
December 31, 2024 -13.28M
December 31, 2023 -14.46M
December 31, 2022 -32.14M
December 31, 2021 -20.27M
December 31, 2020 -14.08M
December 31, 2019 -9.711M
Date Value
December 31, 2018 -9.301M
December 31, 2017 -10.97M
December 31, 2016
December 31, 2015 -11.90M
December 31, 2014 -10.77M
December 31, 2013 -6.865M
December 31, 2012 -7.477M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Myriad Genetics, Inc. 1.80M
BioRestorative Therapies, Inc. -10.79M
CareDx, Inc. 42.03M
Natera, Inc. 215.30M
Sera Prognostics, Inc. -25.62M